PERSPECTA

News from every angle

Back to headlines

Lantern Pharma Projects $15B–$20B Market Potential Amid AI Pipeline Advancement

Lantern Pharma has outlined a market potential of $15 billion to $20 billion as its AI-driven drug pipeline advances, indicating intensifying funding needs for its future growth.

30 Mar, 23:53 — 30 Mar, 23:53
PostShare

Sources

Showing 1 of 1 sources